Growth Metrics

Exact Sciences (EXAS) Gains from Investment Securities (2016 - 2025)

Exact Sciences has reported Gains from Investment Securities over the past 16 years, most recently at $4.9 million for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to $4.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.8 million through Dec 2025, up 1252.49% year-over-year, with the annual reading at $26.8 million for FY2025, 11813.78% up from the prior year.
  • Gains from Investment Securities was $4.9 million for Q4 2025 at Exact Sciences, down from $8.7 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $13.3 million in Q3 2021 and troughed at -$26.7 million in Q1 2022.
  • The 5-year median for Gains from Investment Securities is $2.0 million (2023), against an average of -$2.8 million.
  • Year-over-year, Gains from Investment Securities crashed 1838.62% in 2022 and then skyrocketed 178.34% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$1.2 million in 2021, then crashed by 1838.62% to -$23.2 million in 2022, then soared by 72.94% to -$6.3 million in 2023, then soared by 184.42% to $5.3 million in 2024, then fell by 7.63% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Gains from Investment Securities are $4.9 million (Q4 2025), $8.7 million (Q3 2025), and $4.9 million (Q2 2025).